Topic Highlight
Copyright ©The Author(s) 2015.
World J Gastrointest Oncol. Nov 15, 2015; 7(11): 285-291
Published online Nov 15, 2015. doi: 10.4251/wjgo.v7.i11.285
Table 2 Phase II studies on intraperitoneal chemotherapy using taxanes for the treatment of gastric cancer with peritoneal carcinomatosis
Ref.nMethodIntraperitoneally administered agentsMST (mo)1-yr OS (%)2-yr OS (%)5-yr OS (%)
Yonemura et al[38]61NIPSDOC (40 mg) + CBDCA (150 mg)14.467
Ishigami et al[14]40SPICPTX (20 mg/m2)22.678
Fujiwara et al[17]18NIPSDOC (40-60 mg/m2)24.67654
Imano et al[39]35NIPSPTX (80 mg/m2)21.3694614
Yamaguchi et al[15]35SPICPTX (20 mg/m2)17.67745
Fushida et al[16]27SPICDOC (35-50 mg/m2)16.27033